{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:29:48Z","timestamp":1784305788940,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurology, Psychiatry and Brain Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.npbr.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T11:52:14Z","timestamp":1598615534000},"page":"5-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Acute changes in cerebral blood flow after single-infusion ketamine in major depression: A pilot study"],"prefix":"10.1016","volume":"38","author":[{"given":"Sara","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha M.","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Njau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish K.","family":"Sahib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Narr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber M.","family":"Leaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npbr.2020.08.006_bib0005","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41386-018-0136-3","article-title":"The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects","volume":"43","author":"Abdallah","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npbr.2020.08.006_bib0010","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/npp.2016.186","article-title":"Ketamine treatment and global brain connectivity in major depression","volume":"42","author":"Abdallah","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npbr.2020.08.006_bib0015","first-page":"566","article-title":"Prefrontal connectivity and glutamate transmission: Relevance to depression pathophysiology and ketamine treatment","volume":"2","author":"Abdallah","year":"2017","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"key":"10.1016\/j.npbr.2020.08.006_bib0020","series-title":"Key substance use and mental health indicators in the United States: Results from the 2016 national survey on drug use and health","author":"Ahrnsbrak","year":"2017"},{"key":"10.1016\/j.npbr.2020.08.006_bib0025","series-title":"Diagnostic and statistical manual of mental disorders, fourth edition: DSM-IV-TR\u00ae","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.npbr.2020.08.006_bib0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0006-3223(99)00159-6","article-title":"Reduced glutamate in the anterior cingulate cortex in depression: An in vivo proton magnetic resonance spectroscopy study","volume":"47","author":"Auer","year":"2000","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0035","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"Journal of Statistical Software"},{"key":"10.1016\/j.npbr.2020.08.006_bib0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1461145708009516","article-title":"Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: Correlates and predictors of treatment response","volume":"12","author":"Block","year":"2009","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.npbr.2020.08.006_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0253-7176.127258","article-title":"Acute antidepressant effects of intramuscular versus intravenous ketamine","volume":"36","author":"Chilukuri","year":"2014","journal-title":"Indian Journal of Psychological Medicine"},{"key":"10.1016\/j.npbr.2020.08.006_bib0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archgenpsychiatry.2007.37","article-title":"Glutamate and the neural basis of the subjective effects of ketamine: A pharmaco\u2013Magnetic resonance imaging study","volume":"65","author":"Deakin","year":"2008","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0055","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1388-2457(02)00038-X","article-title":"Technical aspects and utility of fMRI using BOLD and ASL","volume":"113","author":"Detre","year":"2002","journal-title":"Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology"},{"key":"10.1016\/j.npbr.2020.08.006_bib0060","first-page":"582","article-title":"Default mode connectivity in major depressive disorder measured up to 10 days after ketamine administration","volume":"84","author":"Evans","year":"2018","journal-title":"Biological Psychiatry, Cannabinoids, Ketamine, Connectivity, and Depression"},{"key":"10.1016\/j.npbr.2020.08.006_bib0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/0970-9185.182085","article-title":"Intravenous sub-anesthetic ketamine for perioperative analgesia","volume":"32","author":"Gorlin","year":"2016","journal-title":"Journal of Anaesthesiology, Clinical Pharmacology"},{"key":"10.1016\/j.npbr.2020.08.006_bib0070","first-page":"21","article-title":"Rating depressive patients","volume":"41","author":"Hamilton","year":"1980","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","article-title":"Reduced prefrontal Glutamate\/Glutamine and \u03b3-Aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy","volume":"64","author":"Hasler","year":"2007","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0080","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2011.03.019","article-title":"Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression","volume":"35","author":"Ibrahim","year":"2011","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0085","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/npp.2011.338","article-title":"Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: Results from a 4-week, double-blind, placebo-controlled study","volume":"37","author":"Ibrahim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npbr.2020.08.006_bib0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","article-title":"Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression","volume":"224","author":"Koike","year":"2011","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.npbr.2020.08.006_bib0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0100","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026","article-title":"A randomized controlled trial of intranasal ketamine in major depressive disorder","volume":"76","author":"Lapidus","year":"2014","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0105","first-page":"4337","article-title":"Desynchronization and plasticity of striato-frontal connectivity in major depressive disorder","volume":"26","author":"Leaver","year":"2016","journal-title":"Cerebral Cortex (New York, NY: 1991)"},{"key":"10.1016\/j.npbr.2020.08.006_bib0110","first-page":"29","article-title":"Use of ketamine in acute cases of suicidality","volume":"12","author":"Lee","year":"2015","journal-title":"Innovations in Clinical Neuroscience"},{"key":"10.1016\/j.npbr.2020.08.006_bib0115","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnhum.2016.00612","article-title":"Ketamine: 50 years of modulating the mind","volume":"10","author":"Li","year":"2016","journal-title":"Frontiers in Human Neuroscience"},{"key":"10.1016\/j.npbr.2020.08.006_bib0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neubiorev.2011.05.014","article-title":"Region and state specific glutamate downregulation in major depressive disorder: A meta-analysis of 1H-MRS findings","volume":"36","author":"Luykx","year":"2012","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.npbr.2020.08.006_bib0125","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2165\/11633130-000000000-00000","article-title":"Targeting the glutamatergic system to treat major depressive disorder: Rationale and progress to date","volume":"72","author":"Mathews","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.npbr.2020.08.006_bib0130","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1017\/S0033291714001603","article-title":"A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes","volume":"45","author":"McGirr","year":"2015","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.npbr.2020.08.006_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2013.10.043","article-title":"Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach","volume":"156","author":"McIntyre","year":"2014","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.npbr.2020.08.006_bib0140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00004647-199605000-00005","article-title":"The metabolic topography of normal aging","volume":"16","author":"Moeller","year":"1996","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.npbr.2020.08.006_bib0145","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"The British Journal of Psychiatry: the Journal of Mental Science"},{"key":"10.1016\/j.npbr.2020.08.006_bib0150","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1017\/S0033291703007931","article-title":"Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression","volume":"33","author":"Michael","year":"2003","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.npbr.2020.08.006_bib0155","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.npp.1300085","article-title":"Neurotrophic effects of electroconvulsive therapy: A proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression","volume":"28","author":"Michael","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npbr.2020.08.006_bib0160","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: Early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"AJP"},{"key":"10.1016\/j.npbr.2020.08.006_bib0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-pharmtox-011613-135950","article-title":"Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: Ketamine and other compounds","volume":"54","author":"Niciu","year":"2014","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.npbr.2020.08.006_bib0170","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s11920-012-0322-7","article-title":"Where in the brain is depression?","volume":"14","author":"Pandya","year":"2012","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.npbr.2020.08.006_bib0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0925-4927(03)00003-9","article-title":"Effective electroconvulsive therapy reverses glutamate\/glutamine deficit in the left anterior cingulum of unipolar depressed patients","volume":"122","author":"Pfleiderer","year":"2003","journal-title":"Psychiatry Research Neuroimaging"},{"key":"10.1016\/j.npbr.2020.08.006_bib0180","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/npp.2009.104","article-title":"Neurocircuitry of mood disorders","volume":"35","author":"Price","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.npbr.2020.08.006_bib0185","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0190","first-page":"610","article-title":"Effects of ketamine on brain activity during emotional processing: Differential findings in depressed versus healthy control participants","volume":"4","author":"Reed","year":"2019","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"key":"10.1016\/j.npbr.2020.08.006_bib0195","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2020.01.017","article-title":"Single and repeated ketamine treatment induces perfusion changes in sensory and limbic networks in major depressive disorder","author":"Sahib","year":"2020","journal-title":"European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology"},{"key":"10.1016\/j.npbr.2020.08.006_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044799","article-title":"Ketamine decreases resting state functional network connectivity in healthy subjects: Implications for antidepressant drug action","volume":"7","author":"Scheidegger","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.npbr.2020.08.006_bib0210","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/eb-2016-102355","article-title":"Ketamine for treatment-resistant depression: Recent developments and clinical applications","volume":"19","author":"Schwartz","year":"2016","journal-title":"Evidence-based Mental Health"},{"key":"10.1016\/j.npbr.2020.08.006_bib0215","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0924-977X(98)00004-2","article-title":"Treatment resistant depression: Methodological overview and operational criteria","volume":"9","author":"Souery","year":"1999","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.npbr.2020.08.006_bib0225","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0973-1229.109335","article-title":"Towards an integrative theory of consciousness: Part 1 (Neurobiological and cognitive models)","volume":"11","author":"Sousa","year":"2013","journal-title":"Mens Sana Monographs"},{"key":"10.1016\/j.npbr.2020.08.006_bib0230","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/mp.2011.171","article-title":"Ketamine effects on brain GABA and glutamate levels with 1H-MRS: Relationship to ketamine-induced psychopathology","volume":"17","author":"Stone","year":"2012","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0235","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/0269881111405359","article-title":"Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: A proton magnetic resonance spectroscopy study","volume":"26","author":"Taylor","year":"2012","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/j.npbr.2020.08.006_bib0240","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.13m08852","article-title":"Ketamine safety and tolerability in clinical trials for treatment-resistant depression","volume":"76","author":"Wan","year":"2015","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.mri.2007.07.003","article-title":"Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx","volume":"26","author":"Wang","year":"2008","journal-title":"Magnetic Resonance Imaging"},{"key":"10.1016\/j.npbr.2020.08.006_bib0250","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v044.i06","article-title":"Working with the DICOM and NIfTI data standards in r","volume":"44","author":"Whitcher","year":"2011","journal-title":"Journal of Statistical Software"},{"key":"10.1016\/j.npbr.2020.08.006_bib0255","first-page":"785","article-title":"Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders","volume":"68","author":"Y\u00fcksel","year":"2010","journal-title":"Biological Psychiatry, Glutamate in Mood Disorders"},{"key":"10.1016\/j.npbr.2020.08.006_bib0260","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.npbr.2020.08.006_bib0265","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00214","article-title":"The age-related perfusion pattern measured with arterial spin labeling MRI in healthy subjects","volume":"10","author":"Zhang","year":"2018","journal-title":"Frontiers in Aging Neuroscience"}],"container-title":["Neurology, Psychiatry and Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0941950020300555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0941950020300555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:25:03Z","timestamp":1760549103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0941950020300555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":53,"alternative-id":["S0941950020300555"],"URL":"https:\/\/doi.org\/10.1016\/j.npbr.2020.08.006","relation":{},"ISSN":["0941-9500"],"issn-type":[{"value":"0941-9500","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute changes in cerebral blood flow after single-infusion ketamine in major depression: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Neurology, Psychiatry and Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npbr.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}